These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36724875)

  • 1. Evolution of pretransplant cardiac risk factor burden and major adverse cardiovascular events in liver transplant recipients over time.
    Harrington CR; Levy P; Cabrera E; Gao J; Gregory DL; Padilla C; Crespo G; VanWagner LB
    Liver Transpl; 2023 Jun; 29(6):581-590. PubMed ID: 36724875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events.
    Vanwagner LB; Bhave M; Te HS; Feinglass J; Alvarez L; Rinella ME
    Hepatology; 2012 Nov; 56(5):1741-50. PubMed ID: 22611040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Associated With Major Adverse Cardiovascular Events After Liver Transplantation Among a National Sample.
    VanWagner LB; Serper M; Kang R; Levitsky J; Hohmann S; Abecassis M; Skaro A; Lloyd-Jones DM
    Am J Transplant; 2016 Sep; 16(9):2684-94. PubMed ID: 26946333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
    Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M
    Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re-Evaluating Age Limits in Transplantation Consortium.
    Kwong AJ; Devuni D; Wang C; Boike J; Jo J; VanWagner L; Serper M; Jones L; Sharma R; Verna EC; Shor J; German MN; Hristov A; Lee A; Spengler E; Koteish AA; Sehmbey G; Seetharam A; John N; Patel Y; Kappus MR; Couri T; Paul S; Salgia RJ; Nhu Q; Frenette CT; Lai JC; Goel A;
    Liver Transpl; 2020 Nov; 26(11):1492-1503. PubMed ID: 33047893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.
    Noureddin M; Vipani A; Bresee C; Todo T; Kim IK; Alkhouri N; Setiawan VW; Tran T; Ayoub WS; Lu SC; Klein AS; Sundaram V; Nissen NN
    Am J Gastroenterol; 2018 Nov; 113(11):1649-1659. PubMed ID: 29880964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    VanWagner LB; Lapin B; Skaro AI; Lloyd-Jones DM; Rinella ME
    Liver Int; 2015 Dec; 35(12):2575-83. PubMed ID: 25977117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
    Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
    Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis.
    Molnar MZ; Joglekar K; Jiang Y; Cholankeril G; Abdul MKM; Kedia S; Gonzalez HC; Ahmed A; Singal A; Bhamidimarri KR; Aithal GP; Duseja A; Wong VW; Gulnare A; Puri P; Nair S; Eason JD; Satapathy SK;
    Liver Transpl; 2019 Mar; 25(3):399-410. PubMed ID: 30369023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016.
    Golabi P; Bush H; Stepanova M; Locklear CT; Jacobson IM; Mishra A; Trimble G; Erario M; Venkatesan C; Younossi I; Goodman Z; Younossi ZM
    Medicine (Baltimore); 2018 Aug; 97(31):e11518. PubMed ID: 30075518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretransplant coronary artery disease is a predictor for myocardial infarction and cardiac death after liver transplantation.
    Darstein F; Hoppe-Lotichius M; Vollmar J; Weyer-Elberich V; Zimmermann A; Mittler J; Otto G; Lang H; Galle PR; Zimmermann T
    Eur J Intern Med; 2018 May; 51():41-45. PubMed ID: 29229303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times.
    Gitto S; Marra F; De Maria N; Bihl F; Villa E; Andreone P; Burra P
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):173-178. PubMed ID: 30791778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil.
    D'Avola D; Cuervas-Mons V; Martí J; Ortiz de Urbina J; Lladó L; Jimenez C; Otero E; Suarez F; Rodrigo JM; Gómez MA; Fraga E; Lopez P; Serrano MT; Rios A; Fábrega E; Herrero JI
    Liver Transpl; 2017 Apr; 23(4):498-509. PubMed ID: 28160394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future Trends in Demand for Liver Transplant: Birth Cohort Effects Among Patients With NASH and HCC.
    Shingina A; DeWitt PE; Dodge JL; Biggins SW; Gralla J; Sprague D; Bambha K
    Transplantation; 2019 Jan; 103(1):140-148. PubMed ID: 30451739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Pretransplant and New-Onset Diabetes After Transplantation on the Risk of Major Adverse Cardiovascular Events in Kidney Transplant Recipients: A Population-based Cohort Study.
    Lim WH; Lok CE; Kim SJ; Knoll G; Shah BR; Naylor K; Luo B; Vinegar M; Dixon SN; Hawley C; Ooi E; Viecelli A; Wong G
    Transplantation; 2021 Nov; 105(11):2470-2481. PubMed ID: 33560726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of post-liver transplant complications and NASH-related cirrhosis in postmenopausal women.
    Parra NS; Schafer M; Ross HM; Bruckbauer J; Yan B; Chen SL; Khan A; Tholey DM; Halegoua-DeMarzio D
    Ann Hepatol; 2024; 29(1):101157. PubMed ID: 37742744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity.
    van den Berg EH; Douwes RM; de Meijer VE; Schreuder TCMA; Blokzijl H
    Dig Liver Dis; 2018 Jan; 50(1):68-75. PubMed ID: 28935188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular filtration rate early after liver transplantation independently predicts atherosclerotic events.
    Hassouneh R; Patel S; Shen S; Bui A; Syed T; Flynn S; Patel V; Muthiah MD; Sharma A; Bhati C; Siddiqui MS
    Liver Transpl; 2022 Jul; 28(7):1186-1195. PubMed ID: 35124881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation.
    Tokodai K; Karadagi A; Kjaernet F; Romano A; Ericzon BG; Nowak G
    Scand J Gastroenterol; 2019 Feb; 54(2):233-239. PubMed ID: 30999770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation.
    Narayanan P; Mara K; Izzy M; Dierkhising R; Heimbach J; Allen AM; Watt KD
    Transplantation; 2019 Jan; 103(1):e14-e21. PubMed ID: 29994981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.